Duquesne research team finds early autism markers

Updated: Dec 26, 2021

In 2006, Dr. Scott Faber and Howard Kingston were told they were crazy for believing that autism was not a genetic disease, but rather an autoimmune one. However, this did not stop the pair from carryi

ng out research for 14 years to prove those who doubted them wrong.

During their research, Faber and Kingston developed their own measurement system in order to asses the likelihood of a child developing autism. This measurement system utilized 21 different biomarkers to test for autism.

One of the biomarker measurements they invented involved tracking glutathione (GHS), an antioxidant found in the body that reduces oxidative stress. Improper levels of the oxidized variation of GSH can place children at risk of suffering from irreversible brain damage. Once the GSH oxidizes and becomes glutathione disulfide (GSSG), there is no more GSH left. If all of the GSH turns into GSSG, then the child’s immune system is no longer functioning properly. In fact, if there is anywhere from 3 to 5% of GSSG in the body instead of GSH, the immune system will begin to weaken.

In terms of its relationship to autism, children under the age of two that show signs of having a weak or underdeveloped immune system are at a greater risk of developing autism.

For additional reading, please research: Glutathione, Sulfur and Wahls Protocol

Source: Duquesne Duke

0 views0 comments